Spire Healthcare Group plc (LON:SPI - Get Free Report)'s stock price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 214.78 ($2.85) and traded as low as GBX 183.10 ($2.43). Spire Healthcare Group shares last traded at GBX 184.88 ($2.45), with a volume of 1,039,453 shares.
Analysts Set New Price Targets
Separately, Deutsche Bank Aktiengesellschaft dropped their target price on Spire Healthcare Group from GBX 320 ($4.24) to GBX 300 ($3.98) and set a "buy" rating on the stock in a report on Thursday, March 6th.
View Our Latest Research Report on SPI
Spire Healthcare Group Price Performance
The stock has a 50 day moving average price of GBX 192.53 and a two-hundred day moving average price of GBX 214.08. The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70. The company has a market capitalization of £738.50 million, a PE ratio of 26.17, a P/E/G ratio of 1.06 and a beta of 0.96.
Spire Healthcare Group (LON:SPI - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The company reported GBX 8.80 ($0.12) earnings per share for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. Equities analysts forecast that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.
Spire Healthcare Group Increases Dividend
The firm also recently announced a dividend, which will be paid on Friday, June 20th. Shareholders of record on Thursday, May 22nd will be issued a GBX 2.30 ($0.03) dividend. The ex-dividend date is Thursday, May 22nd. This represents a yield of 1.29%. This is a positive change from Spire Healthcare Group's previous dividend of $2.10. Spire Healthcare Group's dividend payout ratio (DPR) is 42.70%.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Further Reading
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
